Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

IGC Pharma (IGC) Short-Term Debt issuances (2016 - 2017)

Historic Short-Term Debt issuances for Pharma (IGC) over the last 9 years, with Q4 2017 value amounting to $76911.0.

  • Pharma's Short-Term Debt issuances rose 37703.7% to $76911.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$448428.0, marking a year-over-year increase of 1576.54%. This contributed to the annual value of -$476190.0 for FY2017, which is 6198.37% up from last year.
  • According to the latest figures from Q4 2017, Pharma's Short-Term Debt issuances is $76911.0, which was up 37703.7% from -$76911.0 recorded in Q3 2017.
  • In the past 5 years, Pharma's Short-Term Debt issuances ranged from a high of $414321.0 in Q1 2015 and a low of -$766903.0 during Q3 2015
  • Over the past 5 years, Pharma's median Short-Term Debt issuances value was -$2797.0 (recorded in 2014), while the average stood at -$75444.4.
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first crashed by 2524436.07% in 2015, then soared by 37703.7% in 2017.
  • Over the past 5 years, Pharma's Short-Term Debt issuances (Quarter) stood at $101999.0 in 2013, then tumbled by 143.45% to -$44322.0 in 2014, then surged by 148.39% to $21447.0 in 2015, then plummeted by 229.44% to -$27762.0 in 2016, then skyrocketed by 377.04% to $76911.0 in 2017.
  • Its last three reported values are $76911.0 in Q4 2017, -$76911.0 for Q3 2017, and -$448428.0 during Q1 2017.